Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
New Supplement Timelines, Categories Proposed For BsUFA III
Apr 28 2021
•
By
Derrick Gingery
Changes to the supplement approval process could help biosimilars come to market faster in the US. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Biosimilars
More from Biosimilars & Generics